Article info
Clinical and epidemiological research
Extended report
Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors
- Correspondence to Dr Timothy Beukelman, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA; tbeukelman{at}peds.uab.edu
Citation
Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors
Publication history
- Received October 29, 2017
- Revised January 28, 2018
- Accepted January 30, 2018
- First published February 9, 2018.
Online issue publication
June 12, 2018
Article Versions
- Previous version (9 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.